[go: up one dir, main page]

Receptors, GABA-A

"Receptors, GABA-A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop.


expand / collapse Publications
This graph shows the total number of publications written about "Receptors, GABA-A" by people in this website by year, and whether "Receptors, GABA-A" was a major or minor topic of these publications.
Below are the most recent publications written about "Receptors, GABA-A" by people in Profiles.
  1. Displacement of extracellular chloride by immobile anionic constituents of the brain's extracellular matrix. J Physiol. 2025 Jan; 603(2):353-378.
    View in: PubMed
  2. A Multimodal, In Vivo Approach for Assessing Structurally and Phenotypically Related Neuroactive Molecules. ACS Chem Neurosci. 2024 Nov 20; 15(22):4171-4184.
    View in: PubMed
  3. Novel neuropharmacological activity of citrus lime (Citrus aurantifolia): A standardized lime peel supplement enhances non-rapid eye movement sleep by activating the GABA type A receptor. Biomed Pharmacother. 2024 Oct; 179:117410.
    View in: PubMed
  4. A therapeutic small molecule enhances γ-oscillations and improves cognition/memory in Alzheimer's disease model mice. Proc Natl Acad Sci U S A. 2024 Aug 13; 121(33):e2400420121.
    View in: PubMed
  5. Structural insights into GABAA receptor potentiation by Quaalude. Nat Commun. 2024 Jun 19; 15(1):5244.
    View in: PubMed
  6. The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1. Metabolism. 2024 Oct; 159:155942.
    View in: PubMed
  7. TRPM2 and CaMKII Signaling Drives Excessive GABAergic Synaptic Inhibition Following Ischemia. J Neurosci. 2024 May 08; 44(19).
    View in: PubMed
  8. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel. Biochem Pharmacol. 2024 05; 223:116183.
    View in: PubMed
  9. Postsynaptic receptors regulate presynaptic transmitter stability through transsynaptic bridges. Proc Natl Acad Sci U S A. 2024 Apr 09; 121(15):e2318041121.
    View in: PubMed
  10. Mapping of multiple neurotransmitter receptor subtypes and distinct protein complexes to the connectome. Neuron. 2024 Mar 20; 112(6):942-958.e13.
    View in: PubMed